Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lifco Ab ( ($SE:LIFCO.B) ) has shared an update.
Lifco AB has agreed to acquire all shares in Karl Kaps GmbH & Co. KG, a German niche manufacturer of medical and dental microscopes based in Asslar with 33 employees and 2024 net sales of about EUR 10.1 million. Karl Kaps will be integrated into Lifco’s Dental business area, with consolidation planned for the first quarter of 2026, and the deal is not expected to have a significant impact on Lifco’s earnings or financial position for the 2026 financial year, underscoring Lifco’s strategy of adding specialised, market‑leading companies to strengthen its dental portfolio without materially altering its overall financial profile.
The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK370.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.
More about Lifco Ab
Lifco AB is a Swedish industrial group that acquires and develops market‑leading niche businesses, focusing on sustainable earnings growth and strong cash flows. Operating through three business areas—Dental, Demolition & Tools, and Systems Solutions—the group manages a strongly decentralised portfolio of 257 operating companies in 34 countries and reported 2024 net sales of SEK 26.1 billion with an EBITA margin of 22.6%.
Average Trading Volume: 294,494
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK156.7B
For a thorough assessment of LIFCO.B stock, go to TipRanks’ Stock Analysis page.